US$ 28.97
tirzepatide elmhurst Tirzepatide | Personalized Weight Loss
Description
The more meaningful question is not: Do patients regain weight after stopping GLP-1s? It is: How should we transition patients from pharmacologic support to long-term weight maintenance? Obesity is a chronic disease

Semaglutide (Ozempic, Wegovy) has become a popular obesity drug because it promotes dramatic weight loss

Effective drug

#Gastroenterology #PharmaInnovation #PatientCare #HealthcareIndia #Colozo #RegulatoryMilestone #ConstipationRelief #ChronicConstipation #ChronicConstipationManagement #GutHealthMatters #HealthcareInnovation #InclusiveHealthcare #FirstInClass #GoodHealthCantWait #WeAreDrReddys | 78 comments on LinkedIn

Increased heart rate

*Breaking* Top-line results positive of the highly anticipated #SOUL trial, the first powered CVOT of an oral #GLP1RA 14% reduction in MACE with oral semaglutide among 9,650 people with T2D and established CV disease and/or CKD
